FL-ELEVATE-PRIZE
4.11.2021 17:02:13 CET | Business Wire | Press release
The Elevate Prize Foundation, in collaboration with MIT Solve, announced today the winners of the second annual Elevate Prize, which distributes $5 million across 10 diverse social entrepreneurs working to solve pressing issues around the world. This year’s winners, selected from a pool of over 1,200 applicants, stand out for their innovative approaches to global causes, such as LGBTQIA+ rights, access to health care, social justice reform and sustainability.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211104005942/en/
Founded in 2019 by Joseph Deitch, The Elevate Prize Foundation aims to “Make Good Famous” by partnering with rising activists and social entrepreneurs and providing them with resources to raise visibility of their work, multiplying their ability to mobilize support – whether online or on-the-ground. The 2021 winners of the Elevate Prize will each receive a minimum of $300,000 in prize funding, as well as leadership development services, social media training, mentorship, and other support needed to reach a wider audience and grow their following.
“This year’s Elevate Prize winners are an exceptional group of creative problem-solvers who have managed to catalyze change through such challenging times,” said Joseph Deitch, Founder, Elevate Prize Foundation. “In a world that is increasingly looking for leaders to lead … and to inspire us, we are so fortunate to have these incredible individuals and organizations show us the way. We look forward to partnering and co-creating with them to expand their impact, and to share their stories with the world.”
The winners of the 2021 Elevate Prize are:
- Amanda Alexander, Detroit Justice Center , which works alongside communities to transform the justice system and promote equitable and fair cities.
- Krista Donaldson, Equalize Health , which provides access to medical care and addresses the leading causes of maternal and newborn mortality through innovative tech.
- Aparna Hegde, ARMMAN , which uses mobile technology to enable healthy pregnancies, safe deliveries, and healthy childhoods.
- Kaushik Kappangantulu, Kheyti , which designs, adapts and implements low-cost farming solutions to help farmers increase yield and predictability of produce, offering a “greenhouse-in-a-box” – an affordable, modular greenhouse bundled with full-stack services.
- Nisha Ligon, Ubongo , the leading children’s entertainment producer in Africa, which harnesses the power of entertainment to reduce inequalities in education across Africa.
- Heejae Lim, TalkingPoints , which connects and empowers families in under-resourced, multilingual communities, using communications technology to bridge crucial gaps between students, families, teachers, and schools.
- Uzoma Orchingwa , Ameelio , which works to reduce the prison population, decrease recidivism and ensure incarcerated individuals can stay in touch with the outside through free-to-use communication apps.
- Alexander Roque, Ali Forney Center , a space dedicated to empowering homeless LGBTQIA+ youth to live independently and get back on their feet.
- Rebecca van Bergen, Nest , which supports the responsible growth and creative engagement of the artisan and maker economy to build a world of greater gender equity and economic inclusion.
- Tony Weaver , Weird Enough Productions , which runs a national education program that combines diverse comic books with an anti-racist and equity-based learning curricula.
“We’re thrilled to highlight such a radically diverse group of winners this year, all working on a wide-range of important issues around the world,” said Carolina García Jayaram, CEO of The Elevate Prize Foundation. “We look forward to helping grow their audience and impact, ultimately making philanthropy and social change more accessible to all.”
The Elevate Prize 2021 winners were selected by a renowned judging panel, composed of purpose-driven leaders in business, academia, media and beyond, including Diane von Furstenberg, fashion designer and philanthropist; Maria Elena Salinas, journalist and CBS news contributor; Stephanie Mehta, Editor-in-Chief of Fast Company; and Natalie Tran, Executive Director of the CAA Foundation.
About The Elevate Prize Foundation
Founded in 2019 by businessman, philanthropist, and author Joseph Deitch, The Elevate Prize Foundation aims to serve as an engine for social good by funding, guiding, and scaling the platforms of social entrepreneurs. The Foundation’s signature program is its annual Elevate Prize, which is awarded to 10 or more global leaders tackling pressing issues in innovative ways. The Elevate Prize Catalyst Award, another one of the Foundation’s programs, recognizes prominent individuals for their commitment to inspiring global social action and using their influence for the good of humanity. Through the Elevate Giving program, the Foundation allows everyday people the opportunity to engage in philanthropy. For more information, visit www.elevateprize.org and follow @ElevatePrize on Facebook , Instagram , LinkedIn , and Twitter .
About MIT Solve
Solve is an initiative of the Massachusetts Institute of Technology (MIT) with a mission to solve world challenges. Solve is a marketplace for social impact innovation. Through open innovation Challenges, Solve finds incredible tech-based social entrepreneurs all around the world. Solve then brings together MIT’s innovation ecosystem and a community of Members to fund and support these entrepreneurs to help them drive lasting, transformational impact. Join Solve on this journey at solve.mit.edu .
View source version on businesswire.com: https://www.businesswire.com/news/home/20211104005942/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press release
Potential first-in-class GPC3 x 4-1BB bispecific achieves a 36% confirmed response rate at Phase 3 dose and favorable safety profile in heavily pretreated liver cancerBrain-penetrant PRMT5 inhibitor shows promising antitumor and CNS activity in the largest publicly shared MTAP-deficient datasetFirst clinical data of CEA-targeting ADC demonstrates encouraging and sustained responses in CEAhigh NSCLC BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to dise
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release
Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
